(Q33265315)

24 July 2017

Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension (English)

1 reference

24 July 2017

arterial hypertension

0 references

1 reference

1 reference

M Sean McMurtry

1

1 reference

24 July 2017

Rohit Moudgil

2

1 reference

24 July 2017

Kyoko Hashimoto

3

1 reference

24 July 2017

Sandra Bonnet

4

1 reference

24 July 2017

Evangelos D Michelakis

5

1 reference

24 July 2017

Stephen L Archer

6

1 reference

24 July 2017

1 December 2006

1 reference

American Journal of Physiology - Lung Cellular and Molecular Physiology

24 July 2017

1 reference

24 July 2017

292

1 reference

24 July 2017

4

1 reference

24 July 2017

L872-8

1 reference

Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels

24 July 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

BMP type II receptor is required for gastrulation and early development of mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Endothelin receptor antagonists in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Cellular and molecular pathobiology of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Pulmonary arterial hypertension in France: results from a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Genetic basis of pulmonary arterial hypertension: current understanding and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Pathologic assessment of vasculopathies in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00309.2006

10.1152/AJPLUNG.00309.2006

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference